🇺🇸 FDA
Patent

US 8636978

Cyclized NGR peptide compounds, compositions, and methods of their use

granted A61PA61P35/00

Quick answer

US patent 8636978 (Cyclized NGR peptide compounds, compositions, and methods of their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61P, A61P35/00